Actively Recruiting
The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA)
Led by Ruijin Hospital · Updated on 2024-05-28
2000
Participants Needed
1
Research Sites
186 weeks
Total Duration
On this page
Sponsors
R
Ruijin Hospital
Lead Sponsor
R
RenJi Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
1. Establish an IgAN cohort collaboration group and expert committee to carry out registration research. 2. Construct IgAN structured data set standards, formulate structured data collection templates of diagnosis and treatment , and establish multi-center data integration systems on this basis. 3. Establish a standardized IgAN database for combined Hospital Information System and the big data platform of the Medical Federation. 4. Develop IgAN database managements and open standards for data sharing, and carry out high-quality clinical or basic research.
CONDITIONS
Official Title
The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- No age limit, no gender limit
- Kidney biopsy confirmed primary IgA nephropathy
- Voluntarily sign the informed consent form
You will not qualify if you...
- IgA nephropathy caused by systemic diseases such as systemic lupus erythematosus or allergic purpura
- IgA nephropathy diagnosed clinically but not confirmed by pathology
- Patient refuses to participate
- Patients deemed unsuitable for the study by investigators
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ruijin Hospital, Shanghai JiaoTong University School of Medicine
Shanghai, Shanghai Municipality, China, 200025
Actively Recruiting
Research Team
J
Jingyuan Xie
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here